C. Sun et al.
Phytochemistry 160 (2019) 56–60
600 MHz spectrometer (Bruker BioSpin Corp., MA, USA). HR-ESI-MS
data were obtained on a Waters ACQUITY™ UPLC-Q-TOF-MS (Waters
Corp., Milford, USA). Silica gel (200–300 mesh, Qingdao Haiyang
Chemical Co., Qingdao, China), D101-type macroporous resin (Baoen
Corp., Cangzhou, China), and Sephadex LH-20 (Pharmacia, Stockholm,
Sweden) were used for CC. RP-HPLC was performed on a Shimadzu LC
2010 AHT instrument, using a YMC ODS-AQ column (20 × 250 mm,
5 μm, YMC, Kyoto, Japan). GC-MS was conducted on an Agilent 7890A-
5975C instrument (Agilent Technologies, Inc., CA, USA). TLC was
carried out with GF254 plates (Qingdao Haiyang Chemical Co.,
Qingdao, China). Spots were visualized by spraying with 10% H SO in
2
4
EtOH followed by heating. The analytically pure reagents were from
Sinopharm Chemical Reagent Co., (Shanghai, China).
Fig. 4. The repressive effect of compounds 1–6 & 8 on the growth of BPH-1 cells
(n = 3).
4.2. Plant materials
C-6′, δ 63.3) indicated the sugar moiety was β-glucose (Gorin and
C
The leaves of Metapanax delavayi (Araliaceae) were collected from
Mazurek, 1975). The β-D-glucose of the sugar moiety was determined
by acid hydrolysis and comparison with an authentic sample by GC-MS.
Thus, the structure of 3 was assigned as 5-epi-eudesm-15-carbox-
aldehyde-6-O-β-D-glucopyranoside-1α,6β-diol, named liangwanoside A.
Their inhibitory activities against BPH-1 cells of compounds 1–6, 8
were studied in vitro (Fig. 4). In previous reports, compound 7 had ef-
fects of increasing alkaline phosphatase and inhibition of arachidonic
acid release activity (Bukhari et al., 2015; Mao et al., 2014). As 7 was
known compound and had a low content in M. delavayi leaves, we didn't
investigate its activity on anti-BPH. The result showed that compounds
Lanping County, Yunnan Province, China (GPS coordinates:
6°27′34.64″N, 99°19′1.25″E), in October 2014, autumn, and identified
by one of authors Prof. Xiaobo Li. A voucher specimen (20141001) was
deposited at School of Pharmacy, Shanghai Jiao Tong University.
2
4.3. Extraction and isolation
Dried and powdered leaves of M. delavayi (1 kg) were extracted
three times by water (3 × 10 L, 1 h each) under reflux. The combined
extraction filtrated with eight layers of gauze, and then concentrated
under reduced pressure to obtain a crude aqueous extract (380 g),
1
–6 inhibited cell proliferation for 48 h, and 8 didn't exhibit inhibitory
effect obviously. The inhibition rates of compound 1–6 were from 3.9%
to 10.9% at 50 μM, and from 9.9% to 21.0% at 100 μM, respectively. It
was reported that compound 4 possessed hepatoprotective effect
which was suspended in H
column. After eluting with H
eluted with 10%, 20%, 30%, 40% and 95% EtOH, to afford six fractions
F1–F6). F3 (13.6 g) was subjected to silica gel CC (CH Cl /MeOH,
5:1–3:1, v/v) to afford eight fractions (F3-1–F3-8). F3-2 was then se-
parated by silica gel CC eluted with CH Cl /MeOH (15:1–3:1), then
purified by RP-HPLC using MeCN/H O (10% v/v, 2 mL/min) as mobile
phase to yield compound 3 (95.1 mg, t = 17.9 min). F4 (20.7 g) was
chromatographed by silica gel CC using CH Cl /MeOH/H O (4:1:0.1,
v/v/v) as mobile phase, to yield 12 fractions. F4-1 to F4-12. F4-3
63.3 mg) was separated by repeated Sephadex LH-20 and purified by
2
O and chromatographed over a D101
2
O, the D101 column was successively
(
Zhang et al., 2018), and 5 showed the activity of IL-6 formation in-
(
2
2
hibition (Tsuji et al., 1997). In our present study, compounds 4–5 also
exhibited the anti-BPH activity in vivo, their inhibitory rates were
1
2
2
1
5.0 ± 1.4%, 16.0 ± 1.5% at 100 μM, respectively. But the un-
2
described compounds 1–3 showed stronger inhibitory effect with in-
R
hibitory rates of 18.5 ± 2.4%, 21.0 ± 2.4% and 18.4 ± 0.7% at
2
2
2
1
00 μM, respectively. The absorption of glycosides was often involved
metabolism such as deglycosylation to the aglycone after oral admin-
istration, and the prototype components as well as their aglycone could
be absorbed into plasma (Zhou et al., 2018). In our study, the glycosides
(
RP-HPLC MeCN/H
pound 7 (2.3 mg, t
CC with CH Cl
0 fractions, F5-1 to F5-30. F5-9 (72.6 mg) was separated via RP-HPLC
MeCN/H O, 20:80, v/v, 2 mL/min) to afford compound 4 (33.0 mg,
= 17.5 min). F5-8 (80.1 mg) was subsequently subjected to silica gel
CC eluting with CH Cl /MeOH/H O (4:1:0.1, v/v), and purified by RP-
HPLC using MeCN/H O (30% v/v, 2 mL/min, UV 210 nm) as mobile
phase to yield compound 1 (34.5 mg, t = 13.5 min). F5-7 (63.3 mg)
was repeated on a silica gel column, Sephadex LH-20 and RP-HPLC
MeCN/H O, 30:70, v/v, 2 mL/min) to yield compound 2 (27.0 mg,
= 23.5 min). F5-2 (47.6 mg) was subjected to passage over a silica
gel column eluted with CH Cl –MeOH (8:1, v/v) to give 13 fractions.
The eighth fraction (32.7 mg) was further purified over Sephadex LH-20
and RP-HPLC (MeCN/H O, 30:70, v/v, 2 mL/min, UV 210 nm) to give
2
O (10% v/v, 2 mL/min, UV 210 nm) to give com-
R
= 32.0 min). F5 (30.5 g) was separated by silica gel
(
1–2, 4–6) show stronger inhibitory activity of anti-proliferation on
2
2 2
/MeOH/H O (4:1:0.1, v/v/v) as mobile phase, to yield
BPH-1 cells than their aglycone (8). Their activities in vivo remain to be
further investigated.
3
(
2
t
R
3. Conclusion
2
2
2
2
A total of seven compounds were isolated from the aqueous extract
of M. delavayi leaves, including three undescribed and four known
compounds. Compounds 1–2, 4–6 were derivatives of serratagenic acid,
R
(
2
3
and 7 were sesquiterpenes. Compounds 1–6, which were demon-
t
R
strated to displayed moderate inhibitory activity against BPH-1 cells,
would be developed to the precursors of novel anti-BPH drugs.
Considering the large contents of the derivatives of serratagenic acid in
M. delavayi leaves, they might be the major bioactive components
against BPH in vivo and need to be further studied.
2
2
2
compound 6 (18.8 mg). F5-20 (11.3 g) was further separated by re-
peated Sephadex LH-20 eluted with MeOH to afford compound 5
(
10.2 g). Compound 5 (300 mg) was hydrolyzed by heating in 2 M HCl
(50 mL). The reaction mixture was partitioned between EtOAc (50 mL)
and H O each, and the EtOAc extract was subjected to silica gel CC
(CH Cl /MeOH/H O, 30:1:0.04, v/v/v) to afford compound 8
4. Experimental
2
4.1. General experimental procedures
2
2
2
(
63.2 mg), its identity was confirmed by comparison with published
Specific rotations were determined on a JASCO P-2000 polarimeter
NMR spectroscopic data.
(
Hachioji, Tokyo, Japan). UV spectra were recorded using a UV-1102
UV–vis spectrophotometer (Techcomp, Shanghai, China). IR spectra
were determined on an Equinox 55 FT-IR spectrometer (Bruker Optics
Inc., MA, USA). NMR spectra were recorded on a Bruker Avance
4.3.1. Liangwanoside III (1)
25
White powder; [α] –16.8 (c 0.1, MeOH); UV (MeOH) λmax (log ε)
D
210 (3.61) nm; IR (KBr) νmax 3082, 2886, 1594, 1441, 1372, 1366,
59